Navigation Links
Simons Foundation grant boosts brain tumor research
Date:2/1/2008

NEW YORK, January 31, 2008 A $10 million commitment from James H. and Marilyn H. Simons through the Simons Foundation will support preclinical initiatives undertaken as part of Memorial Sloan-Ketterings new Brain Tumor Center (BTC).

Established in 2007, the BTC is designed to achieve fundamental new insights into the molecular and cellular properties that drive tumor development and growth. Investigators plan to apply that knowledge to the creation of therapies that target cancer cells and the abnormal signaling pathways needed to maintain them.

With its emphasis on carrying discoveries from the basic and translational research laboratory all the way to clinical trials, the BTC offers the potential for meaningful progress against one of the most challenging forms of cancer.

We are grateful to Jim and Marilyn Simons for their foresight and generosity in helping to get the Brain Tumor Center off to a strong start, said Harold Varmus, Memorial Sloan-Ketterings President. The work to be done through the BTC is highly complex, but absolutely essential, and we welcome the Foundations support in moving forward.

The grant from the Simons Foundation will underwrite preclinical studies of new therapies to confirm that they produce their desired effect in animal models. There currently exists no drug pipeline developed specifically for gliomas, and such preclinical work is an essential step in the design of new therapies for use in humans.

Brain cancer poses a particular challenge to treatment, in part because of the difficulties involved in getting drugs to cross the blood-brain barrier, which physically shields the brain from chemicals circulating in the body. There are also concerns about the potential side effects of drugs that do succeed in entering the brain. The highly precise treatments developed through the BTC will be designed to destroy cancer cells while sparing nearby sensitive tissues an especially important consideration in dealing with the brain.

Helping to guide the development of the BTC have been three physicians who bring a breadth of expertise to the project: Lisa M. DeAngelis, Chair of the Department of Neurology, Philip H. Gutin, Chair of the Department of Neurosurgery, and Eric C. Holland, a neurosurgeon and member of the Sloan-Kettering Institutes Cancer Biology and Genetics Program who is the BTCs founding director.

My colleagues and I are overwhelmed by the confidence that the Simons Foundation has shown in the work of the Brain Tumor Center and in the collaborative spirit that is at its heart, said Dr. Holland. This gift provides solid footings for the program and will dramatically accelerate the development of its preclinical and clinical components, which together are key to identifying new therapeutic approaches.

The Simons Foundations support for the Brain Tumor Center extends its commitment to promoting innovation in mathematics, physics, and other sciences a commitment exemplified by its Autism Research Initiative, which supports wide-ranging neuroscience research with the goal of improving the diagnosis, treatment, and prevention of autism and related conditions. Indeed, work conducted through the BTC into the biology of gliomas which arise from supporting tissue known as glia has the potential to shed new light on the role of glial cells in autism and a variety of neurodegenerative and neurodevelopmental disorders.


'/>"/>

Contact: Christine Hickey
hickey1@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

Related medicine news :

1. The Chrysler Foundation and Kenosha Engine Plant Donate $100,000 to New YMCA Aquatics Center
2. The UV Foundation Announces February is Vitamin D Deficiency Month
3. Michael J. Fox Foundation awards up to $3 million to industry teams
4. AMERIGROUP Foundation Announces Winners of Word About Health Contest
5. Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery
6. Fernandez Appointed to Blue Cross Foundation Board
7. Inspector Hector(R), National Childrens Oral Health Foundation Kick Off Events for National Childrens Dental Health Month
8. Asthma Foundation Announces 2008 Asthma Capitals, Knoxville on Top Again
9. Helios Education Foundation Invests $6.5 Million in New Partnership with TGen
10. The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations
11. American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... Columbus, OH (PRWEB) , ... December 05, 2016 ... ... novel engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy ... usability in various healthcare settings. , Over the last 60 years, studies ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known ... for in a show called "Front Page". One of the forthcoming episodes examines mammogram ... rates have plummeted in large part due to early detection. Like any other disease, ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual SMU ... presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016   Pairnomix, LLC, a genetic research company ... by the White House, today announced that findings from its ... of candidate therapies for a patient with epileptic encephalopathy caused ... presented at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process ...
(Date:12/4/2016)... , Dec. 3, 2016  Findings from ... safety of CTL019, an investigational chimeric antigen receptor ... pediatric and young adult patients with B-cell acute ... an oral session at the 58th American Society ... 3, 4:00-5:30 p.m.). The global Phase II study ...
(Date:12/2/2016)... British Columbia , December 2, 2016 bioLytical Laboratories, ... de la Compañía, el INSTI HIV Self Test , a los miembros ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology: